TILD

DRUG2 trials

Sponsors

Sun Pharmaceutical Industries Limited

Conditions

Active Psoriatic Arthritis

Phase 3

Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1)

CompletedNCT04314544

Sun Pharmaceutical Industries LimitedActive Psoriatic Arthritis

Start: 2020-07-01End: 2025-12-22Updated: 2026-01-16

Efficacy and Safety of Tildrakizumab Compared to Placebo in Anti-TNF naïve Subjects With Active Psoriatic Arthritis II (INSPIRE 2)

Active, not recruitingNCT04314531

Sun Pharmaceutical Industries LimitedActive Psoriatic Arthritis

Start: 2020-07-01End: 2026-04-01Updated: 2026-03-10